Amphastar Pharmaceuticals (AMPH) PT Lowered to $20 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Amphastar Pharma (AMPH) Tops Q1 EPS by 2c
May 8, 2017 4:08 PM EDTAmphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of $0.09, $0.02 better than the analyst estimate of $0.07. Revenue for the quarter came in at $56.67 million versus the consensus estimate of $19.49 million.
For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.
... More


